• 中国科学论文统计源期刊
  • 中国科技核心期刊
  • 美国化学文摘(CA)来源期刊
  • 日本科学技术振兴机构数据库(JST)

JOURNAL OF CLINICAL TRANSFUSION AND LABORATORY MEDICINE ›› 2026, Vol. 28 ›› Issue (5): 828-836.DOI: 10.3969/j.issn.1671-2587.2026.05.022

Previous Articles     Next Articles

Transfusion-Related Risks in Patients with Chronic Kidney Disease: A Systematic Overview and Clinical Management Strategies

WU Ling, GAN Xinyu, TAN Qiang, REN Lina, PENG Tao   

  1. The General Hospital of Western Theater Command, Chengdu 610083
  • Received:2026-09-02 Revised:2026-09-22 Online:2026-10-20 Published:2026-11-11

Abstract: Patients with chronic kidney disease (CKD) have a significantly higher transfusion rate than the general population owing to renal anemia, coagulopathy and perioperative requirements, and their transfusion-related risks are characterized by multiple and overlapping risks. Current evidence indicates that CKD is an important independent risk factor for transfusion-associated circulatory overload (TACO) (OR=27, 95%CI: 5.4—143); that the incidence of transfusion-related acute lung injury (TRALI) under active surveillance varies with blood component, being 0.17, 0.31 and 3.19 per 10 000 units transfused for red blood cells, platelets and plasma, respectively; and that only 44.2% of patients on maintenance hemodialysis in China achieve the target hemoglobin level of 110~130 g/L. This review systematically elaborates the risk profiles and underlying mechanisms of TACO, TRALI, red blood cell alloimmunization, iron overload, transfusion-transmitted infections (TTIs) and transfusion-associated graft-versus-host disease (TA-GVHD), and proposes prevention and control strategies including restrictive transfusion, appropriate blood component selection, risk-stratified extended antigen matching, irradiation and leukoreduction. The roles of erythropoiesis-stimulating agents (ESAs), hypoxia-inducible factor prolyl hydroxylase inhibitors (HIF-PHIs) and patient blood management (PBM) in reducing the need for transfusion are also discussed. This review aims to provide an evidence-based reference for transfusion medicine-led decision-making and quality control of transfusion in patients with CKD.

Key words: Chronic kidney disease, Transfusion-related risk, Transfusion-associated circulatory overload, Alloimmunization, Iron overload, Patient blood management

CLC Number: